Smith & Nephew Stock Price, News & Analysis (NYSE:SNN)

$34.98 0.08 (0.23 %)
(As of 01/18/2018 07:07 AM ET)
Previous Close$34.90
Today's Range$34.81 - $35.10
52-Week Range$29.76 - $40.43
Volume460,400 shs
Average Volume492,882 shs
Market Capitalization$15.27 billion
P/E RatioN/A
Dividend Yield1.72%
Beta0.71

About Smith & Nephew (NYSE:SNN)

Smith & Nephew logoSmith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Receive SNN News and Ratings via Email

Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryN/A
SectorMedical
SymbolNYSE:SNN
CUSIPN/A
Phone44-20-7401-7646

Debt

Debt-to-Equity Ratio0.38%
Current Ratio2.18%
Quick Ratio1.08%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio19.76
P/E Growth2.65

Sales & Book Value

Annual Sales$4.67 billion
Price / Sales3.28
Cash Flow$2.74 per share
Price / Cash12.76
Book Value$9.04 per share
Price / Book3.87

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees15,644
Outstanding Shares437,610,000

Smith & Nephew (NYSE:SNN) Frequently Asked Questions

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a semiannual dividend on Monday, August 28th. Shareholders of record on Friday, October 6th will be paid a dividend of $0.246 per share on Wednesday, November 1st. This represents a yield of 1.37%. The ex-dividend date is Thursday, October 5th. View Smith & Nephew's Dividend History.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) issued its quarterly earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.39 by $0.59. View Smith & Nephew's Earnings History.

Where is Smith & Nephew's stock going? Where will Smith & Nephew's stock price be in 2018?

4 equities research analysts have issued 1 year price targets for Smith & Nephew's shares. Their forecasts range from $45.00 to $45.00. On average, they anticipate Smith & Nephew's share price to reach $45.00 in the next year. View Analyst Ratings for Smith & Nephew.

What are Wall Street analysts saying about Smith & Nephew stock?

Here are some recent quotes from research analysts about Smith & Nephew stock:

  • 1. According to Zacks Investment Research, "Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physician advantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment to deliver new levels of healing to patients throughout the world " (11/8/2017)
  • 2. Canaccord Genuity analysts commented, "We initiate coverage of Smith & Nephew with a BUY rating and a $42 target as we believe the broad product portfolio, spanning both orthopedics and wound care, provides a strong foundation from which the company can realize accelerating top-line growth. Further, with two major restructuring programs now complete we believe SNN is better positioned to focus on commercial execution and operating leverage." (10/11/2017)

Who are some of Smith & Nephew's key competitors?

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the folowing people:

  • Olivier Bohuon, Chief Executive Officer, Executive Director (Age 58)
  • Graham Baker, Chief Financial Officer, Executive Director (Age 48)
  • Rodrigo Bianchi, President, Asia Pacific and Emerging Markets (Age 57)
  • Brad Cannon, President, Europe and Canada (Age 49)
  • Vasant Padmanabhan Ph.D., President - Research & Development (Age 50)
  • Cyrille Petit, Chief Corporate Development Officer, President - Global Business Services (Age 46)
  • Matthew R. Stober, President - Global Operations (Age 49)
  • Glenn S. Warner, President, US (Age 54)
  • Elga Lohler, Chief Human Resource Officer (Age 49)
  • John W. Campo, Chief Legal Officer (Age 62)

Who owns Smith & Nephew stock?

Smith & Nephew's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.10%) and Bank of Montreal Can (0.06%). View Institutional Ownership Trends for Smith & Nephew.

Who sold Smith & Nephew stock? Who is selling Smith & Nephew stock?

Smith & Nephew's stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co.. View Insider Buying and Selling for Smith & Nephew.

Who bought Smith & Nephew stock? Who is buying Smith & Nephew stock?

Smith & Nephew's stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can. View Insider Buying and Selling for Smith & Nephew.

How do I buy Smith & Nephew stock?

Shares of Smith & Nephew can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Smith & Nephew's stock price today?

One share of Smith & Nephew stock can currently be purchased for approximately $34.98.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of $15.27 billion and generates $4.67 billion in revenue each year. Smith & Nephew employs 15,644 workers across the globe.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is 15 ADAM STREET, LONDON X0, WC2N 6LA. The medical equipment provider can be reached via phone at 44-20-7401-7646 or via email at [email protected]


MarketBeat Community Rating for Smith & Nephew (SNN)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  275 (Vote Outperform)
Underperform Votes:  502 (Vote Underperform)
Total Votes:  777
MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Smith & Nephew (NYSE:SNN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyHold
Consensus Rating Score: 2.252.252.502.29
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $45.00$42.00$42.00N/A
Price Target Upside: 27.08% upside16.25% upside11.08% upsideN/A

Smith & Nephew (NYSE:SNN) Consensus Price Target History

Price Target History for Smith & Nephew (NYSE:SNN)

Smith & Nephew (NYSE:SNN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/5/2018Canaccord GenuityReiterated RatingBuy$45.00LowView Rating Details
12/11/2017Morgan StanleyDowngradeOverweight -> Equal WeightLowView Rating Details
2/27/2017Goldman Sachs GroupDowngradeBuy -> NeutralN/AView Rating Details
2/15/2017Berenberg BankReiterated RatingHoldN/AView Rating Details
11/8/2016Bank of AmericaReiterated RatingBuyN/AView Rating Details
11/7/2016Deutsche BankReiterated RatingHoldN/AView Rating Details
8/10/2016Beaufort SecuritiesReiterated RatingHoldN/AView Rating Details
8/10/2016BarclaysDowngradeOverweight -> Equal WeightN/AView Rating Details
5/9/2016Jefferies GroupUpgradeHold -> BuyN/AView Rating Details
3/17/2016NomuraInitiated CoverageNeutralN/AView Rating Details
2/26/2016Cantor FitzgeraldInitiated CoverageHoldN/AView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Smith & Nephew (NYSE:SNN) Earnings History and Estimates Chart

Earnings by Quarter for Smith & Nephew (NYSE:SNN)

Smith & Nephew (NYSE SNN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2015Q4$0.51$0.51$1.29 billion$1.25 billionViewN/AView Earnings Details
11/17/2014$0.39$0.98ViewN/AView Earnings Details
10/29/2014$0.38$0.39$1.15 billion$1.15 billionViewN/AView Earnings Details
8/1/2014$0.94$1.02$1.13 billion$1.15 billionViewN/AView Earnings Details
5/1/2014$0.93$0.89$1.09 billion$1.07 billionViewN/AView Earnings Details
2/6/2014Q4$1.13$1.16$1.17 billion$1.18 billionViewN/AView Earnings Details
10/31/2013Q3 2013$0.34$0.34ViewN/AView Earnings Details
8/1/2013Q2 2013$0.36$0.36ViewN/AView Earnings Details
5/2/2013Q1 2013$0.38$0.37ViewN/AView Earnings Details
2/7/2013Q4 2012$0.42$0.43ViewN/AView Earnings Details
11/1/2012Q3 2012$0.34$0.33ViewN/AView Earnings Details
8/2/2012Q2 2012$0.32$0.36ViewN/AView Earnings Details
5/3/2012Q1 2012$0.38$0.39ViewN/AView Earnings Details
2/2/2012Q4 2011$0.43$0.44ViewN/AView Earnings Details
11/4/2011Q3 2011$0.34$0.32ViewN/AView Earnings Details
8/5/2011Q2 2011$0.38$0.36ViewN/AView Earnings Details
5/5/2011Q1 2011$0.38$0.37ViewN/AView Earnings Details
11/23/2010Q3 2010$0.31$0.30ViewN/AView Earnings Details
8/5/2010Q2 2010$0.34$0.34ViewN/AView Earnings Details
2/11/2010Q4 2009$0.37$0.41ViewN/AView Earnings Details
11/6/2009Q3 2009$0.30$0.34ViewN/AView Earnings Details
7/30/2009Q2 2009$0.30$0.31ViewN/AView Earnings Details
2/12/2009Q4 2008$0.34$0.33ViewN/AView Earnings Details
11/6/2008Q3 2008$0.28$0.23ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Smith & Nephew (NYSE:SNN) Earnings Estimates

2018 EPS Consensus Estimate: $1.95
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.00$0.00$0.00
Q2 20181$0.90$0.90$0.90
Q3 20181$0.00$0.00$0.00
Q4 20181$1.05$1.05$1.05
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Smith & Nephew (NYSE:SNN) Dividend Information

Most Recent Dividend:11/1/2017
Annual Dividend:$0.61
Dividend Yield:1.74%
Dividend Growth:-23.80% (3 Year Average)
Payout Ratio:34.46% (Based on This Year's Estimates)
32.80% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Smith & Nephew (NYSE:SNN)

Smith & Nephew (NYSE:SNN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/28/2017semiannual$0.251.37%10/5/201710/6/201711/1/2017
2/28/2017semiannual$0.372.42%3/29/20173/31/20175/10/2017
9/1/2016$0.2410/5/201610/7/201610/25/2016
2/8/2016$0.374/20/20164/22/20165/11/2016
4/9/2015semiannual$0.372.13%4/15/20154/17/20155/6/2015
9/9/2014semiannual$0.551.28%10/22/201410/24/201411/12/2014
2/20/2014semiannual$0.852.12%4/17/20144/22/20145/7/2014
8/28/2013special$0.522.73%10/9/201310/11/201310/29/2013
3/11/2013semiannual$0.812.97%4/17/20134/19/20135/8/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Smith & Nephew (NYSE SNN)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Smith & Nephew (NYSE SNN) News Headlines

Source:
DateHeadline
FY2017 Earnings Estimate for Smith & Nephew plc Issued By Northcoast Research (SNN)FY2017 Earnings Estimate for Smith & Nephew plc Issued By Northcoast Research (SNN)
www.americanbankingnews.com - January 8 at 1:34 AM
Canaccord Genuity Reiterates "Buy" Rating for Smith & Nephew (SNN)Canaccord Genuity Reiterates "Buy" Rating for Smith & Nephew (SNN)
www.americanbankingnews.com - January 5 at 1:34 PM
Smith & Nephew plc (SNN) Given Average Recommendation of "Hold" by AnalystsSmith & Nephew plc (SNN) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - January 5 at 11:52 AM
What is Behind Smith & Nephew plc’s (LON:SN.) Superior ROE?What is Behind Smith & Nephew plc’s (LON:SN.) Superior ROE?
finance.yahoo.com - December 22 at 7:49 AM
Smith & Nephew Enters Oversold Territory (SNN)Smith & Nephew Enters Oversold Territory (SNN)
www.nasdaq.com - December 16 at 7:54 AM
Is There Now An Opportunity In Smith & Nephew plc (LON:SN.)?Is There Now An Opportunity In Smith & Nephew plc (LON:SN.)?
finance.yahoo.com - December 15 at 7:42 AM
Smith & Nephews Rotation Medical Deal Aids Tissue Regen ArmSmith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm
finance.yahoo.com - December 13 at 7:53 AM
Smith & Nephew SNATS, Inc. (SNN) Receives Average Recommendation of "Hold" from BrokeragesSmith & Nephew SNATS, Inc. (SNN) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - December 11 at 2:32 PM
Smith & Nephew SNATS (SNN) Downgraded to "Equal" at Morgan StanleySmith & Nephew SNATS (SNN) Downgraded to "Equal" at Morgan Stanley
www.americanbankingnews.com - December 11 at 10:36 AM
Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound CareSmith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care
finance.yahoo.com - December 11 at 7:23 AM
Smith & Nephew Buys Tissue Regeneration Developer Rotation MedicalSmith & Nephew Buys Tissue Regeneration Developer Rotation Medical
www.nasdaq.com - December 6 at 8:13 AM
Analyzing Smith & Nephew SNATS (SNN) and Its PeersAnalyzing Smith & Nephew SNATS (SNN) and Its Peers
www.americanbankingnews.com - December 5 at 1:10 AM
Uroplasty (UPI) versus Smith & Nephew SNATS (SNN) Financial AnalysisUroplasty (UPI) versus Smith & Nephew SNATS (SNN) Financial Analysis
www.americanbankingnews.com - December 4 at 7:58 PM
Critical Comparison: Smith & Nephew SNATS (SNN) and Its RivalsCritical Comparison: Smith & Nephew SNATS (SNN) and Its Rivals
www.americanbankingnews.com - December 2 at 5:36 AM
Smith & Nephew SNATS (SNN) vs. Its Rivals Critical ContrastSmith & Nephew SNATS (SNN) vs. Its Rivals Critical Contrast
www.americanbankingnews.com - November 30 at 7:24 PM
Want To Invest In Smith & Nephew plc (LSE:SN)? Here’s How It Performed LatelyWant To Invest In Smith & Nephew plc (LSE:SN)? Here’s How It Performed Lately
finance.yahoo.com - November 30 at 7:53 AM
Will a 'Huge Tax Cut' Ease Burden for MedTech Players?Will a 'Huge Tax Cut' Ease Burden for MedTech Players?
finance.yahoo.com - November 23 at 12:48 PM
Critical Contrast: Smith & Nephew SNATS (SNN) and Its PeersCritical Contrast: Smith & Nephew SNATS (SNN) and Its Peers
www.americanbankingnews.com - November 22 at 11:10 PM
Critical Review: Smith & Nephew plc (SNN) & Its CompetitorsCritical Review: Smith & Nephew plc (SNN) & Its Competitors
www.americanbankingnews.com - November 19 at 3:26 AM
Stocks Under Scanner in the Medical Equipment Space -- ResMed, Smith & Nephew, Stryker, and Zimmer BiometStocks Under Scanner in the Medical Equipment Space -- ResMed, Smith & Nephew, Stryker, and Zimmer Biomet
www.bizjournals.com - November 18 at 4:58 AM
Smith & Nephew SNATS, Inc. (SNN) Given Average Rating of "Hold" by AnalystsSmith & Nephew SNATS, Inc. (SNN) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - November 16 at 12:18 PM
Stocks Generating Improved Relative Strength: Smith & NephewStocks Generating Improved Relative Strength: Smith & Nephew
finance.yahoo.com - November 10 at 11:26 AM
Jefferies Group Weighs in on Smith & Nephew SNATS, Inc.s FY2020 Earnings (SNN)Jefferies Group Weighs in on Smith & Nephew SNATS, Inc.'s FY2020 Earnings (SNN)
www.americanbankingnews.com - November 8 at 10:44 PM
Northcoast Research Brokers Reduce Earnings Estimates for Smith & Nephew SNATS, Inc. (SNN)Northcoast Research Brokers Reduce Earnings Estimates for Smith & Nephew SNATS, Inc. (SNN)
www.americanbankingnews.com - November 8 at 10:36 AM
Contrasting Smith & Nephew SNATS (SNN) & The CompetitionContrasting Smith & Nephew SNATS (SNN) & The Competition
www.americanbankingnews.com - November 8 at 5:28 AM
Smith & Nephew SNATS, Inc. (SNN) to Post FY2017 Earnings of $1.76 Per Share, Jefferies Group ForecastsSmith & Nephew SNATS, Inc. (SNN) to Post FY2017 Earnings of $1.76 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - November 7 at 6:50 AM
Smith & Nephew SNATS, Inc. (SNN) Given Average Recommendation of "Buy" by BrokeragesSmith & Nephew SNATS, Inc. (SNN) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - October 22 at 1:20 PM
Smith & Nephew Plc : SNN-US: Dividend Analysis : October 06th, 2017 (record date) : By the numbers : October 18, 2017Smith & Nephew Plc : SNN-US: Dividend Analysis : October 06th, 2017 (record date) : By the numbers : October 18, 2017
finance.yahoo.com - October 19 at 9:05 AM
ETFs with exposure to Smith & Nephew Plc : October 18, 2017ETFs with exposure to Smith & Nephew Plc : October 18, 2017
finance.yahoo.com - October 19 at 9:05 AM
FY2017 EPS Estimates for Smith & Nephew SNATS, Inc. (SNN) Raised by AnalystFY2017 EPS Estimates for Smith & Nephew SNATS, Inc. (SNN) Raised by Analyst
www.americanbankingnews.com - October 17 at 8:14 AM
[$$] Elliott Management takes stakes in GEA and Smith & Nephew[$$] Elliott Management takes stakes in GEA and Smith & Nephew
finance.yahoo.com - October 12 at 9:41 AM
Smith & Nephew SNATS, Inc. (SNN) Earns Buy Rating from Analysts at Canaccord GenuitySmith & Nephew SNATS, Inc. (SNN) Earns Buy Rating from Analysts at Canaccord Genuity
www.americanbankingnews.com - October 11 at 8:02 AM
Singers Elliott Builds a Stake in Smith & NephewSinger's Elliott Builds a Stake in Smith & Nephew
finance.yahoo.com - October 11 at 7:53 AM
Elliotts Deal Magic Is Put to the TestElliott's Deal Magic Is Put to the Test
finance.yahoo.com - October 11 at 7:53 AM
Elliott Said to Build Stake in Smith & NephewElliott Said to Build Stake in Smith & Nephew
finance.yahoo.com - October 11 at 7:53 AM
Reviewing Smith & Nephew SNATS (SNN) & Stryker Corporation (SYK)Reviewing Smith & Nephew SNATS (SNN) & Stryker Corporation (SYK)
www.americanbankingnews.com - October 8 at 8:08 PM
ETFs with exposure to Smith & Nephew Plc : October 3, 2017ETFs with exposure to Smith & Nephew Plc : October 3, 2017
finance.yahoo.com - October 3 at 12:38 PM
Contrasting Smith & Nephew SNATS (SNN) and Stryker Corporation (SYK)Contrasting Smith & Nephew SNATS (SNN) and Stryker Corporation (SYK)
www.americanbankingnews.com - September 27 at 6:28 PM
Smith & Nephew SNATS, Inc. (SNN) Receives Average Rating of "Buy" from AnalystsSmith & Nephew SNATS, Inc. (SNN) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - September 27 at 12:54 PM
Second Sight Medical Products (EYES) & Smith & Nephew SNATS (SNN) Head-To-Head AnalysisSecond Sight Medical Products (EYES) & Smith & Nephew SNATS (SNN) Head-To-Head Analysis
www.americanbankingnews.com - September 23 at 4:22 AM
Critical Review: Smith & Nephew SNATS (SNN) and HeartWare International (HTWR)Critical Review: Smith & Nephew SNATS (SNN) and HeartWare International (HTWR)
www.americanbankingnews.com - September 19 at 6:10 PM
Critical Analysis: Smith & Nephew SNATS (SNN) & HeartWare International (HTWR)Critical Analysis: Smith & Nephew SNATS (SNN) & HeartWare International (HTWR)
www.americanbankingnews.com - September 18 at 2:30 PM
ETFs with exposure to Smith & Nephew Plc : September 14, 2017ETFs with exposure to Smith & Nephew Plc : September 14, 2017
finance.yahoo.com - September 14 at 10:19 AM
Head-To-Head Comparison: Glaukos Corporation (GKOS) vs. Smith & Nephew SNATS (SNN)Head-To-Head Comparison: Glaukos Corporation (GKOS) vs. Smith & Nephew SNATS (SNN)
www.americanbankingnews.com - September 3 at 10:08 AM
Smith & Nephew SNATS, Inc. (SNN) Receives Consensus Recommendation of "Buy" from BrokeragesSmith & Nephew SNATS, Inc. (SNN) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 2 at 12:58 PM
Contrasting St Jude Medical (STJ) & Smith & Nephew SNATS (SNN)Contrasting St Jude Medical (STJ) & Smith & Nephew SNATS (SNN)
www.americanbankingnews.com - September 2 at 12:20 PM
Contrasting Smith & Nephew SNATS (SNN) and Second Sight Medical Products (EYES)Contrasting Smith & Nephew SNATS (SNN) and Second Sight Medical Products (EYES)
www.americanbankingnews.com - September 1 at 12:20 PM
Smith & Nephew SNATS, Inc. (SNN) Plans Semiannual Dividend of $0.25Smith & Nephew SNATS, Inc. (SNN) Plans Semiannual Dividend of $0.25
www.americanbankingnews.com - August 28 at 6:26 PM
ETFs with exposure to Smith & Nephew Plc : August 25, 2017ETFs with exposure to Smith & Nephew Plc : August 25, 2017
finance.yahoo.com - August 25 at 9:23 PM
ETFs with exposure to Smith & Nephew Plc : August 14, 2017ETFs with exposure to Smith & Nephew Plc : August 14, 2017
finance.yahoo.com - August 15 at 7:07 AM

SEC Filings

Smith & Nephew (NYSE:SNN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Smith & Nephew (NYSE:SNN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Smith & Nephew (NYSE SNN) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.